ATCC announces award from national institute of allergy and infectious diseases to support its preclinical services for biopharmaceutical product development Post author: Post published:November 13, 2023 Post category:uncategorized ATCC today announced that it has been awarded an Indefinite Delivery/Indefinite Quantity (IDIQ) contract. You Might Also Like Liver function discovery could revolutionize treatments for cardiovascular disease October 19, 2024 Majority of Americans retrospectively support key COVID-19 policies, poll reveals June 17, 2024 Life expectancy in India suffered large and unequal declines during the COVID-19 pandemic July 24, 2024
Life expectancy in India suffered large and unequal declines during the COVID-19 pandemic July 24, 2024